REFERENCES
- Paterson DL, Swindells S, Mohr J, et al. Adherence to pro-tease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000,133:21–30.
- Gross R, Bilker WB, Friedman HM, Strom BL. Effect of ad-herence to newly initiated antiretroviral therapy on plasma viral load. AIDS. 2001,15:2109–2117.
- Bangsberg DR, Hecht FM, Charlebois ED, et al. Adher-ence to protease inhibitors, HIV-1 viral load, and develop-ment of drug resistance in an indigent population. AIDS. 2000;14:357–366.
- Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann Intern Med. 2003;139:810–816.
- Mocroft A, Ruiz L, Reiss P, et al. Virological rebound after suppression on highly active antiretroviral therapy. AIDS. 2003;17:1741–1751.
- Gross R, Yip B, Re VL 3rd, et al. A simple, dynamic mea-sure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006;194:1108–1114.
- Holmes WC, Bilker WB, Wang H, Chapman J, Gross R. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr. 2007;46(3):323–327.
- Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001134: 968–977.
- Haylir DV, Bassett R, Levitan D, et al. Prevalence and pre-dictive value of intermittent viremia with combination HIV therapy. JAMA. 2001;286:171–179.
- Nettles RE, Kieffer TL, Kwon P, et al. Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART. JAMA. 2005;293:817–829.
- Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin EpidemioL 2004;57:1107–1110.
- Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ. Barriers to use of electronic adherence moni-toring in an HIV clinic. Ann Pharmacother 2001;35:1010–1015.
- Gardner EM, Sharma S, Peng G, et al. Differential adher-ence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS. 2008;22:75–82.
- Nicastri E, Leone S, Angeletti C, et al. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother. 2007;60:724–732.
- Goldie SJ, Paltiel AD, Weinstein MC, et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003;115:632–641.